Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 3
2013 5
2014 3
2016 1
2017 2
2018 8
2019 7
2020 6
2021 9
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study).
Kimura Y, Yamaguchi S, Suzuki T, Kato J, Chiba S, Hirakawa N, Yamaguchi K, Tanabe Y, Takatsuna H, Kenyoshi Y, Shiosakai K, Sakai M, Iseki M. Kimura Y, et al. Among authors: shiosakai k. Pain Ther. 2021 Jun;10(1):711-727. doi: 10.1007/s40122-021-00255-y. Epub 2021 Apr 15. Pain Ther. 2021. PMID: 33856660 Free PMC article.
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM).
Niikura N, Yamanaka T, Nomura H, Shiraishi K, Kusama H, Yamamoto M, Matsuura K, Inoue K, Takahara S, Kita S, Yamaguchi M, Aruga T, Shibata N, Shimomura A, Ozaki Y, Sakai S, Kiga Y, Izutani T, Shiosakai K, Tsurutani J. Niikura N, et al. Among authors: shiosakai k. NPJ Breast Cancer. 2023 Oct 11;9(1):82. doi: 10.1038/s41523-023-00584-5. NPJ Breast Cancer. 2023. PMID: 37821514 Free PMC article.
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH).
Motoki H, Inobe Y, Fukui T, Iwasaki A, Hiramitsu S, Koyama S, Masuda I, Sekimura N, Yamamoto K, Sato A, Komatsu M, Taguchi T, Shiosakai K, Sugimoto K, Kuwahara K. Motoki H, et al. Among authors: shiosakai k. Adv Ther. 2023 Nov;40(11):5055-5075. doi: 10.1007/s12325-023-02633-8. Epub 2023 Sep 21. Adv Ther. 2023. PMID: 37733211 Free PMC article.
Nighttime home blood pressure lowering effect of esaxerenone in patients with uncontrolled nocturnal hypertension: the EARLY-NH study.
Kario K, Nishizawa M, Kato M, Ishii H, Uchiyama K, Nagai M, Takahashi N, Asakura T, Shiraiwa T, Yoshida T, Kaneshiro M, Taguchi T, Shiosakai K, Sugimoto K. Kario K, et al. Among authors: shiosakai k. Hypertens Res. 2023 Jul;46(7):1782-1794. doi: 10.1038/s41440-023-01292-0. Epub 2023 May 12. Hypertens Res. 2023. PMID: 37173430 Free PMC article.
Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study.
Miyazaki T, Matsumoto K, Sato T, Sano I, Furukawa K, Shimoyama K, Kamohara R, Suzuki M, Kondou M, Ikeda N, Tabata S, Shiosakai K, Nagayasu T; ADMIT-NeP Study group. Miyazaki T, et al. Among authors: shiosakai k. BMC Cancer. 2024 Jan 15;24(1):80. doi: 10.1186/s12885-023-11708-2. BMC Cancer. 2024. PMID: 38225552 Free PMC article. Clinical Trial.
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study.
Uchida HA, Nakajima H, Hashimoto M, Nakamura A, Nunoue T, Murakami K, Hosoya T, Komoto K, Taguchi T, Akasaka T, Shiosakai K, Sugimoto K, Wada J; EX-DKD investigators. Uchida HA, et al. Among authors: shiosakai k. Adv Ther. 2022 Nov;39(11):5158-5175. doi: 10.1007/s12325-022-02294-z. Epub 2022 Sep 7. Adv Ther. 2022. PMID: 36070133 Free PMC article.
52 results